Skip to main content
Log in

Comment to the paper “The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma” by Burzynski et al.

  • Commentary
  • Published:
Child's Nervous System Aims and scope Submit manuscript

The Original Article was published on 10 April 2014

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Burzynski SR, Janicki TJ, Burzynski GS, Marszalek A (2014) The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. Childs Nerv Syst. doi:10.1007/s00381-014-2401-z

  2. Woff JE, Rytting ME, Vats TS, Zage PE, Ater JL, Woo S, Kuttesch J, Ketonen L, Mahajan A (2012) Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience. J Neurooncol 106(2):391–397

  3. Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248

    Article  PubMed  Google Scholar 

  4. Dellaretti M, Reyns N, Touzet G, Dubois F, Gusmao S, Pereira JL, Blond S (2012) Diffuse pontine tumor: prognostic factors. J Neurosurg 117:810–814

    Article  PubMed  Google Scholar 

  5. Dellaretti M, Touzet G, Dueyns N, Dbois F, Gusmao S, Pereira JL, Blond S (2012) Diffuse pontine tumor: prognostic factors

  6. Roujeau T, Machado G, Garnet MR, Miquel C, Puget S, Geoerger B, Grill J, Boddaert N, Di Rocco F, Zerah M, Sainte-Rose C (2007) J Neursurg 107(1 Suppl Pediatrics):1–4

    Google Scholar 

  7. Warren KE (2012) Diffuse intrinsic pontine glioma: poise for progress. Front Oncol 2:205

    Article  PubMed Central  PubMed  Google Scholar 

  8. Burzynski SR (2004) The present state of antineoplaston research (1). Integr Cancer Ther 3(1):47–58

    Article  CAS  PubMed  Google Scholar 

  9. Patil SS, Burzynski SR, Mrowczynski E, Grela K, Chittur SV (2012) Phenylacetylglutaminate and phenylacetate in combination upregulate VDUP1, casuse cell cycle blockade and apoptosis in U87 glioblastoma cells. JCT 3:192–200

    Article  CAS  Google Scholar 

  10. Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, Bourgey M, Bourque G, Montpetit A, Bourret G, Lepage P, Fleming A, Lichter P, Kool M, von Deimling A, Sturm D, Korshunov A, Faury D, Jones DT, Majewski J, Pfister SM, Jabado N, Hawkins C (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine glioma. Acta Neuropathol 124:439–447

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Saratsis AM, Kambhampati M, Snyder K, Yadavilli S, Devaney JM, Harmon B, Hall J, Raabe EH, An P, Weingart M, Rood BR, Magge SN, MacDonald TJ, Packer RJ, Nazarian J (2014) Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes. Acta Neuropathol 127:881–895

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tai-Tong Wong.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wong, TT. Comment to the paper “The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brain stem glioma” by Burzynski et al.. Childs Nerv Syst 30, 2069–2070 (2014). https://doi.org/10.1007/s00381-014-2515-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-014-2515-3

Keywords

Navigation